title: Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting.
abstract: OBJECTIVE
  Polymeric micelles were designed for targeting of a water-insoluble anticancer agent, camptothecin (CPT). Chemical structures of inner core segment were optimized to achieve high incorporation efficiency and stable CPT-loaded micelles.
  
  
  METHODS
  Poly(ethylene glycol)-poly(beta-benzyl L-aspartate) block copolymer (PEG-PBLA) was synthesized. The PBLA chain was modified by alkaline hydrolysis of its benzyl group followed by esterification with benzyl, n-butyl, and lauryl groups. Incorporation of CPT into micelles was carried out by an evaporation method. The stability of drug-loaded micelles was studied by gel-permeation chromatography (GPC), and their in vitro release behaviors were analyzed.
  
  
  RESULTS
  CPT was incorporated into polymeric micelles constructed by various block copolymers. Among the esterified groups, block copolymers with high benzyl ester contents showed high CPT loading efficiency and stable CPT-loaded micelles. In chain lengths, 5-27 Bz-69 showed the highest incorporation efficiency. In contrast, 5-52 Bz-67, which had a longer hydrophobic chain, showed low incorporation efficiency. Release of CPT from the micelles was dependent on the benzyl contents and chain lengths. Sustained release was obtained when the benzyl content was high.
  
  
  CONCLUSIONS
  CPT was successfully incorporated into polymeric micelles with high efficiency and stability by optimizing chemical structures of the inner core segment.
authors.affiliation: Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Kawada-cho 8-1, Shinjuku-ku, Tokyo 162-8666, Japan.
authors.forename: Praneet
authors.initials: P
authors.lastname: Opanasopit
authors.forename: Masayuki
authors.initials: M
authors.lastname: Yokoyama
authors.forename: Masato
authors.initials: M
authors.lastname: Watanabe
authors.forename: Kumi
authors.initials: K
authors.lastname: Kawano
authors.forename: Yoshie
authors.initials: Y
authors.lastname: Maitani
authors.forename: Teruo
authors.initials: T
authors.lastname: Okano
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000737:chemistry; D001224:Aspartic Acid; D001704:Biopolymers; D002021:Buffers; D002166:Camptothecin / Q000008:administration & dosage* / Q000737:chemistry; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D016503:Drug Delivery Systems; D007783:Lactones; D008823:Micelles; D010710:Phosphates / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry*; D011506:Proteins / Q000737:chemistry*; D011721:Pyrenes / Q000737:chemistry
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D001704:Biopolymers; D002021:Buffers; D007783:Lactones; D008823:Micelles; D010710:Phosphates; D011506:Proteins; D011721:Pyrenes; C416210:poly(ethylene oxide)-block-poly(beta-benzyl aspartate); D001224:Aspartic Acid; D011092:Polyethylene Glycols; D002166:Camptothecin